There are 15 resources available
Welcome and introduction
Presenter: Sebastian Stintzing
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
First port of call: Optimizing 1L outcomes in RAS wt mCRC
Presenter: Clara Montagut Viladot
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
Where next? Treatment sequencing in RAS wt mCRC
Presenter: Benoist Chibaudel
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
Navigating the evolving continuum of care for BRAF V600E mt mCRC
Presenter: Chiara Cremolini
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
What could be beyond the horizon for the treatment of mCRC?
Presenter: Sebastian Stintzing
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
Q&A/panel discussion and close
Presenter: Sebastian Stintzing
Session: Merck - Where did we come from, where might we go? Exploring the evolving mCRC treatment landscape
Resources:
Webcast
Welcome and introduction
Presenter: Markus Moehler
Session: Amgen - Precision oncology: Latest developments in GI cancer care
Resources:
Webcast
Biomarker-guided treatment in mCRC and the role for combination therapies
Presenter: Hans Prenen
Session: Amgen - Precision oncology: Latest developments in GI cancer care
Resources:
Webcast
Emerging targeted therapies in G/GEJ cancer
Presenter: Markus Moehler
Session: Amgen - Precision oncology: Latest developments in GI cancer care
Resources:
Webcast
Current biomarker testing practices and future considerations for G/GEJ cancers
Presenter: Magali Svrcek
Session: Amgen - Precision oncology: Latest developments in GI cancer care
Resources:
Webcast